European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-05-24

The impact of treatment with acetylcholinesterase inhibitors on Europeans with Alzheimers disease

Cel

AChe I have been shown to afford modest benefits on cognition in AD patients. A systematic review by the Cochrane Collaboration states "the practical importance of these changes to patients is unclear" This study's primary objective is to find clinical evidence for the global efficacy of AChE I. The secondary aim is to develop a picture of the natural history of AD. These outcomes will provide a fundamental insight into the progression and treatment of AD aiding the formulation of European guidelines. This is a prospective 2 year observational study which co-ordinates the centralisation of patient data available within the individual centres. It does not require any modification in prescribing practice of participating centres. Patients will be recruited into either a treated or non-treated patient group and reviewed 6 monthly. The primary outcome measure is a deterioration of one level on the clinical dementia rating scale.

Dziedzina nauki

Program(-y)

Temat(-y)

Zaproszenie do składania wniosków

Data not available

System finansowania

CON - Coordination of research actions

Koordynator

CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
Wkład UE
Brak danych
Adres
Av. de Casselardit, 170
31300 TOULOUSE
Francja

Zobacz na mapie
Koszt całkowity
Brak danych

Uczestnicy (30)

Udostępnij tę stronę

Pobierz

Ostatnia aktualizacja: 13 Czerwca 2006

Moja broszura

Permalink: https://cordis.europa.eu/project/id/QLK6-CT-2002-02645/pl

European Union, 2024